Sjögren's Disease
Sjögren's disease is an autoimmune disorder that primarily affects the body's moisture-producing glands, leading to symptoms such as dry mouth and dry eyes. It can also cause fatigue and joint pain.
Sjögren’s Disease: Sibeprenlimab Treatment Study
We are investigating whether Sibeprenlimab can improve symptoms in people with Sjögren’s Disease compared to a placebo. The study will also look at the safety and tolerability of this new treatment.
1-2 years11-15 visitsEfficacy phase (II)Post-Trial Drug AccessCost ReimbursementInvestigational MedicinesInjectionInfectious DiseasesRheumatology
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have uncontrolled type 2 diabetes, meaning your blood sugar levels are not stable?
- Are you currently taking systemic corticosteroids like prednisone at a dose of 10 mg or less per day?
- Are you pregnant or breastfeeding?
- Do you have another active autoimmune disease that is your main health issue?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sibeprenlimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical Center Medconsult Pleven OOD
Pleven, Bulgaria
University Multiprofile Hospital For Active Treatment Saint Georgi EAD
Plovdiv, Bulgaria
Diagnostics And Consultation Center Convex Ltd.
Sofia, Bulgaria
Sponsor: Otsuka Pharmaceutical Development & Commercialization Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.